Pictet Asset Management (Switzerland)’s Ventyx Biosciences VTYX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$24.8M	Buy	756,656 +11,931	+2%	+$411K	0.03%	418
2023 Q1	$24.9M	Sell	744,725 -483,247	-39%	-$18.8M	0.03%	415
2022 Q4	$40.3M	Buy	1,227,972 +155,989	+15%	+$4.62M	0.06%	314
2022 Q3	$37.4M	Buy	+1,071,983	New	+$23.7M	0.06%	318

Other funds holding VTYX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s VTYX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Ventyx Biosciences (VTYX) stake by 1.6% in Q2 2023, buying an estimated $411K and bringing the position to 756,656 shares worth $24.8M. The position accounts for 0.03% of the portfolio, ranked #418.

Pictet Asset Management (Switzerland) first reported a position in VTYX in Q3 2022 and has held it in 4 quarters since. The position peaked at $40.3M in Q4 2022. 150 funds tracked by Wall St. Rank hold VTYX as of Q2 2023.

Pictet Asset Management (Switzerland) held 756,656 shares of Ventyx Biosciences worth $24.8M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 11,931 Ventyx Biosciences shares in Q2 2023, an estimated $411K.
Ventyx Biosciences made up 0.03% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #418 holding.
Pictet Asset Management (Switzerland) first reported a position in Ventyx Biosciences in Q3 2022 and has held it in 4 quarters since.
Pictet Asset Management (Switzerland)'s Ventyx Biosciences position peaked at $40.3M in Q4 2022.
150 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.